Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biosig Tech Inc | Morgan Lekstrom | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 03 Feb 2026 | 23,500 | 102,500 (0%) | 0% | 3.1 | 71,910 | Common Stock |
| Viavi Soln Inc | Gary W. Staley | SVP Global Sales NSE | Sale of securities on an exchange or to another person at price $ 25.92 per share. | 03 Feb 2026 | 20,742 | 182,810 (0%) | 0% | 25.9 | 537,633 | Common Stock |
| Natural Gas Services Grp Inc | Justin C. Jacobs | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 10,460 | 23,783 (0%) | 0% | - | Common Stock | |
| Natural Gas Services Grp Inc | Justin C. Jacobs | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2026 | 10,460 | 10,461 | - | - | Restricted Stock Units | |
| Natural Gas Services Grp Inc | Justin C. Jacobs | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.52 per share. | 03 Feb 2026 | 4,290 | 19,493 (0%) | 0% | 34.5 | 148,091 | Common Stock |
| First Commonwealth Fin Corp | Todd D. Brice | Director | Purchase of securities on an exchange or from another person at price $ 18.23 per share. | 03 Feb 2026 | 1,000 | 13,500 (0%) | 0% | 18.2 | 18,230 | Common Stock |
| Royal Gold Inc | Mark Isto | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2026 | 580 | 22,043 (0%) | 0% | 0 | Common Stock | |
| Arbutus Biopharma Corp | Tuan Nguyen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 188,400 | 188,400 | - | - | Stock Option (Right to Buy) | |
| Lindblad Expeditions Holdings Inc | Benjamin Bressler | *Founder & CEO of NHA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 87,478 | 222,389 | - | - | Stock Option (right to buy)(2) | |
| Lindblad Expeditions Holdings Inc | Benjamin Bressler | *Founder & CEO of NHA | Sale of securities on an exchange or to another person at price $ 17.08 per share. | 02 Feb 2026 | 87,478 | 23,466 (0%) | 0% | 17.1 | 1,494,203 | Common Stock |
| Lindblad Expeditions Holdings Inc | Benjamin Bressler | *Founder & CEO of NHA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 87,478 | 110,944 (0%) | 0% | 0 | Common Stock | |
| Arbutus Biopharma Corp | Tuan Nguyen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 73,500 | 73,500 (0%) | 0% | 0 | Common Shares | |
| Arbutus Biopharma Corp | Lindsay Androski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 71,700 | 71,700 | - | - | Stock Option (Right to Buy) | |
| SoFi Tech Inc | Arun Pinto | Chief Risk Officer | 02 Feb 2026 | 71,500 | 71,500 | - | - | Prepaid Forward Contract | ||
| Alkermes PLC | Shane M. Cooke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.64 per share. | 02 Feb 2026 | 61,200 | 164,944 (0%) | 0% | 31.6 | 1,936,368 | Ordinary Shares |
| Alkermes PLC | Shane M. Cooke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 61,200 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.02 per share. | 02 Feb 2026 | 32,410 | 39,639 (0%) | 0% | 8.0 | 259,928 | Common Stock |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 32,410 | 0 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Herriot Tabuteau | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 185.60 per share. | 02 Feb 2026 | 32,410 | 7,229 (0%) | 0% | 185.6 | 6,015,296 | Common Stock |
| Alkermes PLC | Shane M. Cooke | Director | Sale of securities on an exchange or to another person at price $ 34.78 per share. | 02 Feb 2026 | 32,113 | 103,744 (0%) | 0% | 34.8 | 1,116,877 | Ordinary Shares |
| Alkermes PLC | Shane M. Cooke | Director | Sale of securities on an exchange or to another person at price $ 34.34 per share. | 02 Feb 2026 | 29,087 | 135,857 (0%) | 0% | 34.3 | 998,795 | Ordinary Shares |
| Arbutus Biopharma Corp | Lindsay Androski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 28,000 | 28,000 (0%) | 0% | 0 | Common Shares | |
| Corning | Eric S. Musser | Retired President | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 02 Feb 2026 | 25,000 | 19,926 (0%) | 0% | 110.0 | 2,750,080 | Common Stock |
| Vir biotech Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 7.71 per share. | 02 Feb 2026 | 22,000 | 1,144,391 (1%) | 0% | 7.7 | 169,671 | Common Stock |
| Abeona Therapeutics Inc | Leila Alland | Director | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 02 Feb 2026 | 18,065 | 173,614 (0%) | 0% | 5.1 | 91,962 | Common Stock |
| Viavi Soln Inc | Gary W. Staley | SVP Global Sales NSE | Sale of securities on an exchange or to another person at price $ 25.82 per share. | 02 Feb 2026 | 17,138 | 203,552 (0%) | 0% | 25.8 | 442,503 | Common Stock |
| Abeona Therapeutics Inc | Eric Crombez | Director | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 02 Feb 2026 | 16,284 | 63,456 (0%) | 0% | 5.1 | 82,895 | Common Stock |
| Fennec Pharma Inc | Rostislav Raykov | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. | 02 Feb 2026 | 15,598 | 108,826 (0%) | 0% | 2.4 | 38,215 | Common shares |
| Fennec Pharma Inc | Rostislav Raykov | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 15,598 | 1,602,988 | - | - | Stock Options | |
| Abeona Therapeutics Inc | Donald A. Wuchterl | Director | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 02 Feb 2026 | 14,814 | 167,935 (0%) | 0% | 5.1 | 75,412 | Common Stock |
| Viavi Soln Inc | Kevin Christopher Siebert | SVP Gen. Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 25.72 per share. | 02 Feb 2026 | 13,577 | 35,648 (0%) | 0% | 25.7 | 349,200 | Common Stock |
| First Mid Bancshares Inc | Joseph R. Dively | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 13,200 | 108,893 (0%) | 0% | 43.6 | 575,256 | Common Stock |
| Edesa Biotech Inc | Pardeep Nijhawan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 11,168 | 512,990 (5%) | 0% | 0 | Common Shares | |
| Fennec Pharma Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 02 Feb 2026 | 10,349 | 98,477 (0%) | 0% | 7.8 | 80,308 | Common shares |
| Graco Inc | Peter J. O'Shea | Pres, Global Industrial Divis | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 8,820 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Graco Inc | Peter J. O'Shea | Pres, Global Industrial Divis | Sale of securities on an exchange or to another person at price $ 88.10 per share. | 02 Feb 2026 | 8,820 | 14,789 (0%) | 0% | 88.1 | 777,007 | Common Stock |
| Graco Inc | Peter J. O'Shea | Pres, Global Industrial Divis | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.85 per share. | 02 Feb 2026 | 8,820 | 23,609 (0%) | 0% | 23.8 | 210,328 | Common Stock |
| EPR Properties | Gregory E. Zimmerman | EVP & Chief Investment Officer | Sale of securities on an exchange or to another person at price $ 53.89 per share. | 02 Feb 2026 | 7,500 | 66,294 (0%) | 0% | 53.9 | 404,192 | Common Shares of Beneficial Interest |
| PACCAR | Laura J. Bloch | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.26 per share. | 02 Feb 2026 | 6,588 | 12,690 (0%) | 0% | 61.3 | 403,581 | Common Stock |
| PACCAR | Laura J. Bloch | Senior Vice President | Sale of securities on an exchange or to another person at price $ 123.57 per share. | 02 Feb 2026 | 6,588 | 6,102 (0%) | 0% | 123.6 | 814,088 | Common Stock |
| PACCAR | Laura J. Bloch | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 6,588 | 0 | - | - | Stock Option | |
| Renasant Corp | Mark Jeanfreau | EVP/General Counsel | Sale of securities on an exchange or to another person at price $ 37.88 per share. | 02 Feb 2026 | 6,000 | 65,172 (0%) | 0% | 37.9 | 227,279 | Common Stock |
| Viavi Soln Inc | Gary W. Staley | SVP Global Sales NSE | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 02 Feb 2026 | 5,646 | 220,690 (0%) | 0% | 25.8 | 145,949 | Common Stock |
| Corning | Michael Paul O'Day | SVP and GM, Optical Comm. | Sale of securities on an exchange or to another person at price $ 110.52 per share. | 02 Feb 2026 | 5,051 | 29,915 (0%) | 0% | 110.5 | 558,232 | Common Stock |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 5,000 | 26,356 | - | - | Employee Stock Option (Right to Buy) | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.34 per share. | 02 Feb 2026 | 5,000 | 66,740 (0%) | 0% | 19.3 | 96,700 | Ordinary Shares |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 02 Feb 2026 | 5,000 | 61,740 (0%) | 0% | 34.2 | 171,225 | Ordinary Shares |
| First Mid Bancshares Inc | Matthew K. Smith | President | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 4,950 | 22,508 (0%) | 0% | 43.6 | 215,721 | Common Stock |
| Viavi Soln Inc | Paul McNab | EVP, Chief Mktg & Stgy Officer | Sale of securities on an exchange or to another person at price $ 25.80 per share. | 02 Feb 2026 | 4,638 | 21,749 (0%) | 0% | 25.8 | 119,660 | Common Stock |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.54 per share. | 02 Feb 2026 | 4,000 | 57,740 (0%) | 0% | 33.5 | 134,160 | Ordinary Shares |
| Genesco Inc | Andrew I. Gray | Senior VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.93 per share. | 02 Feb 2026 | 3,854 | 54,557 (0%) | 0% | 28.9 | 111,496 | Common Stock |
| First Mid Bancshares Inc | Michael L. Taylor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 3,850 | 35,028 (0%) | 0% | 43.6 | 167,783 | Common Stock |
| First Mid Bancshares Inc | Eric S. McRae | EVP, Chief Lending Officer | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 3,850 | 34,679 (0%) | 0% | 43.6 | 167,783 | Common Stock |
| First Mid Bancshares Inc | Jordan D. Read | EVP, CFO & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 3,850 | 11,669 (0%) | 0% | 43.6 | 167,783 | Common Stock |
| Timberland Bancorp Inc | Matthew J. DeBord | Chief Lending Officer, EVP | Sale of securities on an exchange or to another person at price $ 39.53 per share. | 02 Feb 2026 | 3,805 | 5,700 (0%) | 0% | 39.5 | 150,412 | Common Stock, $.01 par value per share |
| Ultragenyx Pharmaceutical Inc | Howard Horn | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 23.56 per share. | 02 Feb 2026 | 3,061 | 88,935 (0%) | 0% | 23.6 | 72,117 | Common Stock |
| First Mid Bancshares Inc | Amanda D. Lewis | EVP, Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,920 | 12,385 (0%) | 0% | 43.6 | 127,254 | Common Stock |
| Dolphin Entertainment Inc | William O’Dowd | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 02 Feb 2026 | 2,900 | 431,690 (2%) | 0% | 1.7 | 4,872 | Common Stock |
| United Rentals | Michael D. Durand | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 791.14 per share. | 02 Feb 2026 | 2,490 | 7,457 (0%) | 0% | 791.1 | 1,969,946 | Common Stock |
| First Mid Bancshares Inc | Clay M. Dean | CEO-First Mid Insurance Group | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,420 | 12,043 (0%) | 0% | 43.6 | 105,464 | Common Stock |
| First Mid Bancshares Inc | Bradley L. Beesley | EVP, CEO First Mid Wealth Mgmt | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,420 | 18,378 (0%) | 0% | 43.6 | 105,464 | Common Stock |
| First Mid Bancshares Inc | Rhonda G. Gatons | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,420 | 11,925 (0%) | 0% | 43.6 | 105,464 | Common Stock |
| First Mid Bancshares Inc | Jason M. Crowder | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,420 | 12,782 (0%) | 0% | 43.6 | 105,464 | Common Stock |
| First Mid Bancshares Inc | Megan E. McElwee | EVP, Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,420 | 8,247 (0%) | 0% | 43.6 | 105,464 | Common Stock |
| First Mid Bancshares Inc | Stas R. Wolak | EVP Chief Retail Banking Ofc. | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,420 | 4,060 (0%) | 0% | 43.6 | 105,464 | Common Stock |
| First Mid Bancshares Inc | Jeremy R. Frieburg | SVP, Chief Information Officer | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 2,315 | 4,557 (0%) | 0% | 43.6 | 100,888 | Common Stock |
| PACCAR | Brice J. Poplawski | Sr. Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.95 per share. | 02 Feb 2026 | 2,200 | 3,103 (0%) | 0% | 72.0 | 158,290 | Common Stock |
| PACCAR | Brice J. Poplawski | Sr. Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 2,200 | 4,170 | - | - | Stock Option | |
| PACCAR | Brice J. Poplawski | Sr. Vice President & CFO | Sale of securities on an exchange or to another person at price $ 123.99 per share. | 02 Feb 2026 | 2,200 | 903 (0%) | 0% | 124.0 | 272,778 | Common Stock |
| Abeona Therapeutics Inc | Mark J. Alvino | Director | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 02 Feb 2026 | 2,000 | 84,065 (0%) | 0% | 5.1 | 10,181 | Common Stock |
| First Fin Bancorp | Gregory A. Harris | President, Wealth Management | Sale of securities on an exchange or to another person at price $ 29.43 per share. | 02 Feb 2026 | 1,821 | 42,431 (0%) | 0% | 29.4 | 53,592 | Common Stock |
| MSC Industrial Direct Co. Inc (Class A) | Rudina Seseri | Director | Sale of securities on an exchange or to another person at price $ 86.83 per share. | 02 Feb 2026 | 1,800 | 6,090 (0%) | 0% | 86.8 | 156,294 | Class A Common Stock, $0.001 par value |
| Velocity Fin Inc | Jeffrey T. Taylor | Executive VP, Capital Markets | Sale of securities on an exchange or to another person at price $ 20.33 per share. | 02 Feb 2026 | 1,772 | 181,115 (0%) | 0% | 20.3 | 36,025 | Common Stock |
| Timberland Bancorp Inc | Matthew J. DeBord | Chief Lending Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 1,600 | 2,400 | - | - | Stock Options (Right to Buy) | |
| Timberland Bancorp Inc | Matthew J. DeBord | Chief Lending Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.23 per share. | 02 Feb 2026 | 1,600 | 8,305 (0%) | 0% | 28.2 | 45,168 | Common Stock, $.01 par value per share |
| Velocity Fin Inc | Mark R. Szczepaniak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.53 per share. | 02 Feb 2026 | 1,573 | 74,692 (0%) | 0% | 20.5 | 32,292 | Common Stock |
| Timberland Bancorp Inc | Matthew J. DeBord | Chief Lending Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 1,200 | 1,200 | - | - | Stock Options (Right to Buy) | |
| Timberland Bancorp Inc | Matthew J. DeBord | Chief Lending Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.40 per share. | 02 Feb 2026 | 1,200 | 9,505 (0%) | 0% | 27.4 | 32,880 | Common Stock, $.01 par value per share |
| First Mid Bancshares Inc | Anya Y. Schuetz | SVP, Director of Project Mgmt | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 1,185 | 3,650 (0%) | 0% | 43.6 | 51,642 | Common Stock |
| Modine Manufacturing Co. | Suresh V. Garimella | Director | Sale of securities on an exchange or to another person at price $ 184.07 per share. | 02 Feb 2026 | 1,100 | 79,856 (0%) | 0% | 184.1 | 202,477 | Common stock |
| Steel Dynamics | Christopher A. Graham | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 1,100 | 68,030 (0%) | 0% | 0 | Common Stock | |
| Timberland Bancorp Inc | Matthew J. DeBord | Chief Lending Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 1,005 | 4,000 | - | - | Stock Options (Right to Buy) | |
| Timberland Bancorp Inc | Matthew J. DeBord | Chief Lending Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share. | 02 Feb 2026 | 1,005 | 6,705 (0%) | 0% | 16.9 | 16,954 | Common Stock, $.01 par value per share |
| ResMed | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 257.03 per share. | 02 Feb 2026 | 1,000 | 85,495 (0%) | 0% | 257.0 | 257,030 | ResMed Common Stock |
| Cytokinetics Inc | Andrew M. Callos | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.63 per share. | 02 Feb 2026 | 886 | 51,326 (0%) | 0% | 37.6 | 33,340 | Common Stock |
| Cytokinetics Inc | Andrew M. Callos | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 886 | 886 | - | - | Incentive Stock Option (Right to Buy) | |
| Cytokinetics Inc | Andrew M. Callos | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 62.10 per share. | 02 Feb 2026 | 886 | 50,440 (0%) | 0% | 62.1 | 55,021 | Common Stock |
| First Mid Bancshares Inc | Mary J. Westerhold | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 3,675 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| First Mid Bancshares Inc | Holly B. Adams | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 156,942 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| First Mid Bancshares Inc | Robert S. Cook | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 17,797 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| First Mid Bancshares Inc | James E. Zimmer | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 5,997 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| First Mid Bancshares Inc | Zachary I. Horn | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 6,724 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| First Mid Bancshares Inc | James Kyle McCurry | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 6,257 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| First Mid Bancshares Inc | Gisele A. Marcus | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 3,400 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| First Mid Bancshares Inc | Alex J. Melvin | Director | Grant, award, or other acquisition of securities at price $ 43.58 per share. | 02 Feb 2026 | 775 | 137,598 (0%) | 0% | 43.6 | 33,775 | Common Stock |
| Esco Tech Inc | Vinod M. Khilnani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 772 | 2,121 | - | - | Restricted Share Units | |
| Esco Tech Inc | David A. Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 772 | 3,414 | - | - | Restricted Share Units | |
| Esco Tech Inc | Robert J. Phillippy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 772 | 21,182 | - | - | Restricted Share Units | |
| Esco Tech Inc | Patrick M. Dewar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 772 | 23,436 | - | - | Restricted Share Units | |
| Esco Tech Inc | Janice L. Hess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 772 | 2,121 | - | - | Restricted Share Units | |
| Esco Tech Inc | Gloria L. Valdez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 772 | 9,523 | - | - | Restricted Share Units | |
| Esco Tech Inc | Penelope M. Conner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 772 | 2,121 | - | - | Restricted Share Units | |
| Sun Country Airlines Holdings Inc | Colton Matthew Snow | SVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.93 per share. | 02 Feb 2026 | 752 | 33,175 | - | 17.9 | 13,482 | Common Stock, par value $0.01 per share |
| First Fin Bankshares Inc | Robert C. Nickles | Director | Purchase of securities on an exchange or from another person at price $ 32.54 per share. | 02 Feb 2026 | 629 | 96,960 (0%) | 0% | 32.5 | 20,468 | Common Stock |
| Steel Dynamics | Matthew Lane Bell | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 609 | 1,299 (0%) | 0% | 0 | Common Stock | |
| Chemung Fin Corp | Thomas R. Tyrrell | Director | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 02 Feb 2026 | 500 | 8,799 (0%) | 0% | 61 | 30,500 | COMMON STOCK |
| First Community Corp | E. Leland Reynolds | Director | Purchase of securities on an exchange or from another person at price $ 29.67 per share. | 02 Feb 2026 | 500 | 30,930 (0%) | 0% | 29.7 | 14,835 | Common Stock |
| Esco Tech Inc | Patrick M. Dewar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 289 | 23,726 | - | - | Restricted Share Units | |
| Steel Dynamics | Chad Bickford | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.57 per share. | 02 Feb 2026 | 287 | 20,791 (0%) | 0% | 179.6 | 51,537 | Common Stock |
| Esco Tech Inc | Gloria L. Valdez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 265 | 9,789 | - | - | Restricted Share Units | |
| SR Bancorp Inc | Robert Mustard | Director | Purchase of securities on an exchange or from another person at price $ 17.05 per share. | 02 Feb 2026 | 250 | 1,250 | - | 17.1 | 4,263 | Common Stock |
| Esco Tech Inc | David A. Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 214 | 3,629 | - | - | Restricted Share Units | |
| Esco Tech Inc | Janice L. Hess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 214 | 2,335 | - | - | Restricted Share Units | |
| Kingsway Fin Services Inc | John T. Fitzgerald | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 13.69 per share. | 02 Feb 2026 | 183 | 1,460,086 (6%) | 0% | 13.7 | 2,505 | Common Stock |
| Steel Dynamics | Christopher A. Graham | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.57 per share. | 02 Feb 2026 | 161 | 67,869 (0%) | 0% | 179.6 | 28,911 | Common Stock |
| Kingsway Fin Services Inc | Kent A. Hansen | CFO & EVP | Purchase of securities on an exchange or from another person at price $ 13.69 per share. | 02 Feb 2026 | 114 | 119,707 (0%) | 0% | 13.7 | 1,561 | Common Stock |
| United Rentals | Shiv Singh | Director | Grant, award, or other acquisition of securities at price $ 783.35 per share. | 02 Feb 2026 | 68 | 7,600 (0%) | 0% | 783.4 | 53,268 | Common Stock |
| Steel Dynamics | Matthew Lane Bell | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.57 per share. | 02 Feb 2026 | 58 | 1,241 (0%) | 0% | 179.6 | 10,415 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 682.45 per share. | 02 Feb 2026 | 22 | 4,260 (0%) | 0% | 682.5 | 15,014 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 686.45 per share. | 02 Feb 2026 | 11 | 4,226 (0%) | 0% | 686.5 | 7,551 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 688.50 per share. | 02 Feb 2026 | 10 | 4,208 (0%) | 0% | 688.5 | 6,885 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 685.30 per share. | 02 Feb 2026 | 10 | 4,237 (0%) | 0% | 685.3 | 6,853 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 687.62 per share. | 02 Feb 2026 | 8 | 4,218 (0%) | 0% | 687.6 | 5,501 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 681.62 per share. | 02 Feb 2026 | 8 | 4,282 (0%) | 0% | 681.6 | 5,453 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 684.71 per share. | 02 Feb 2026 | 7 | 4,247 (0%) | 0% | 684.7 | 4,793 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 683.83 per share. | 02 Feb 2026 | 6 | 4,254 (0%) | 0% | 683.8 | 4,103 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 689.40 per share. | 02 Feb 2026 | 5 | 4,203 (0%) | 0% | 689.4 | 3,447 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 680.50 per share. | 02 Feb 2026 | 4 | 4,290 (0%) | 0% | 680.5 | 2,722 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 676.00 per share. | 02 Feb 2026 | 2 | 4,296 (0%) | 0% | 676 | 1,352 | Common Stock |
| Northrop Grumman | Mark A. Welsh | Director | Sale of securities on an exchange or to another person at price $ 677.50 per share. | 02 Feb 2026 | 2 | 4,294 (0%) | 0% | 677.5 | 1,355 | Common Stock |
| Mereo Biopharma Grp PLC (ADR) | Charles Sermon | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 315,750 | 315,750 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Chrisitne Ann Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 315,750 | 315,750 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Charles Sermon | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 295,000 | 295,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Chrisitne Ann Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 280,000 | 280,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Alexandra Hughes-Wilson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 195,000 | 195,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Alexandra Hughes-Wilson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 183,750 | 183,750 | - | - | Share Options (Right to buy) | |
| Buckle Inc | Dennis H. Nelson | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 120,000 | 444,000 (0%) | 0% | 0 | Common Stock | |
| Mereo Biopharma Grp PLC (ADR) | Charles Sermon | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 105,250 | 105,250 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Chrisitne Ann Fox | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 105,250 | 105,250 | - | - | Share Options (Right to buy) | |
| Apartment Investment & Management Co. (Class A) | Wesley William Powell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.88 per share. | 01 Feb 2026 | 100,170 | 723,136 | - | 5.9 | 589,000 | Class A Common Stock |
| IBM | Arvind Krishna | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 83,028 | 401,716 (0%) | 0% | 0 | Common Stock | |
| JELD-WEN Holding Inc | Jeffrey D. Embt | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 73,529 | 73,529 (0%) | 0% | 0 | Common Stock | |
| Mereo Biopharma Grp PLC (ADR) | Alexandra Hughes-Wilson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 61,250 | 61,250 | - | - | Share Options (Right to buy) | |
| IBM | James J. Kavanaugh | Sr. VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 48,474 | 192,940 (0%) | 0% | 0 | Common Stock | |
| IBM | Robert David Thomas | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 42,247 | 88,258 (0%) | 0% | 0 | Common Stock | |
| IBM | Arvind Krishna | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 303.75 per share. | 01 Feb 2026 | 41,133 | 360,583 (0%) | 0% | 303.8 | 12,494,354 | Common Stock |
| IBM | Gary D. Cohn | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 35,410 | 125,276 (0%) | 0% | 0 | Common Stock | |
| Associated Banc-Corp. | Andrew J. Harmening | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 32,327 | 358,353 (0%) | 0% | 27.3 | 881,234 | Common Stock $0.01 Par Value |
| Solventum | Amy Landucci | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 26,921 | 45,872 | - | - | Common Stock | |
| Solventum | Amy Landucci | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 26,921 | 0 | - | - | Restricted Stock Units | |
| APA | John J. Christmann | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 26,717 | 239,556 | - | - | Restricted Stock / Units | |
| APA | John J. Christmann | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 26,717 | 654,076 (0%) | 0% | 0 | Common Stock | |
| IBM | James J. Kavanaugh | Sr. VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 303.75 per share. | 01 Feb 2026 | 23,816 | 169,124 (0%) | 0% | 303.8 | 7,234,229 | Common Stock |
| IBM | Nickle Jaclyn Lamoreaux | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 23,566 | 65,379 (0%) | 0% | 0 | Common Stock | |
| IBM | Robert David Thomas | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 303.76 per share. | 01 Feb 2026 | 20,879 | 67,379 (0%) | 0% | 303.8 | 6,342,101 | Common Stock |
| IBM | Gary D. Cohn | Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 303.76 per share. | 01 Feb 2026 | 19,111 | 106,165 (0%) | 0% | 303.8 | 5,805,062 | Common Stock |
| Buckle Inc | Brett P. Milkie | SVP Leasing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 18,400 | 68,080 (0%) | 0% | 0 | Common Stock | |
| Buckle Inc | Thomas B. Heacock | Director, SVP Finance, Treasurer, & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 18,400 | 184,950 (0%) | 0% | 0 | Common Stock | |
| Quad/Graphics Inc (Class A) | Donald M. McKenna | EVP, Chief Administrative Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 16,695 | 203,117 (0%) | 0% | 0 | Class A Common Stock | |
| APA | Stephen J. Riney | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 15,202 | 129,967 | - | - | Restricted Stock / Units | |
| APA | Stephen J. Riney | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 15,202 | 27,546 (0%) | 0% | 0 | Common Stock | |
| Campbell's | Daniel L. Poland | EVP / Chief ETO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.01 per share. | 01 Feb 2026 | 14,020 | 97,665 (0%) | 0% | 27.0 | 378,680 | Common Stock |
| Buckle Inc | Jenschke Brady M Fritz | SVP, Gen Counsel, & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 13,000 | 92,000 (0%) | 0% | 0 | Common Stock | |
| IBM | Nickle Jaclyn Lamoreaux | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 303.76 per share. | 01 Feb 2026 | 11,564 | 53,815 (0%) | 0% | 303.8 | 3,512,623 | Common Stock |
| APA | John J. Christmann | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.41 per share. | 01 Feb 2026 | 10,514 | 643,562 (0%) | 0% | 26.4 | 277,675 | Common Stock |
| Solventum | Amy Landucci | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.97 per share. | 01 Feb 2026 | 10,453 | 35,419 | - | 77.0 | 804,567 | Common Stock |
| Postal Realty Trust Inc - Ordinary Shares Cls A | Stephen Michael Bakke | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 10,246 | 10,246 | - | - | Restricted Stock Units | |
| Postal Realty Trust Inc - Ordinary Shares Cls A | Stephen Michael Bakke | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 8,383 | 75,521 | - | - | LTIP Units | |
| DTE Energy | Gerardo Norcia | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.38 per share. | 01 Feb 2026 | 6,903 | 400,360 (0%) | 0% | 134.4 | 927,625 | Common Stock |
| IBM | Anne E. Robinson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 6,318 | 12,572 (0%) | 0% | 0 | Common Stock | |
| Genesco Inc | Mimi Eckel Vaughn | Director, Board Chair, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.93 per share. | 01 Feb 2026 | 6,179 | 398,079 (2%) | 0% | 28.9 | 178,758 | Common Stock |
| APA | Tracey K. Henderson | Executive VP Exploration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 6,158 | 62,968 | - | - | Restricted Stock / Units | |
| APA | Tracey K. Henderson | Executive VP Exploration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 6,158 | 53,150 (0%) | 0% | 0 | Common Stock | |
| APA | Mark D Maddox | Executive VP - Administration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 6,158 | 54,041 | - | - | Restricted Stock / Units | |
| APA | Mark D Maddox | Executive VP - Administration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 6,158 | 79,034 (0%) | 0% | 0 | Common Stock | |
| Eve Holding Inc | Uallace Moreira Lima | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 6,063 | 6,063 | - | 0 | Common Stock | |
| APA | Stephen J. Riney | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.41 per share. | 01 Feb 2026 | 5,982 | 21,564 (0%) | 0% | 26.4 | 157,985 | Common Stock |
| APA | Kimberly O. Warnica | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 5,981 | 5,981 (0%) | 0% | 0 | Common Stock | |
| APA | Kimberly O. Warnica | EVP, CLO & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 5,981 | 30,284 | - | - | Restricted Stock / Units | |
| Blue Foundry Bancorp | James D. Nesci | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.15 per share. | 01 Feb 2026 | 5,272 | 144,767 | - | 13.2 | 69,327 | Common Stock |
| Associated Banc-Corp. | Phillip Trier | EVP | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 5,094 | 27,788 (0%) | 0% | 27.3 | 138,862 | Common Stock $0.01 Par Value |
| Steven Madden Ltd | Edward R. Rosenfeld | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.88 per share. | 01 Feb 2026 | 4,992 | 760,620 (0%) | 0% | 43.9 | 219,049 | Common Stock par value $0.0001 per share |
| NCR Voyix Corp | Beimnet Tadele | EVP & President, Restaurants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 4,941 | 20,338 (0%) | 0% | 0 | Common Stock | |
| NCR Voyix Corp | Beimnet Tadele | EVP & President, Restaurants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 4,941 | 4,941 | - | - | Restricted Stock Units | |
| Associated Banc-Corp. | Randall J. Erickson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,612 | 159,839 (0%) | 0% | 27.3 | 125,723 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Cory L. Nettles | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 46,429 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Eileen A. Kamerick | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 55,864 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Gale E. Klappa | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 25,480 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Judith P. Greffin | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 17,431 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Karen T. Van Lith | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 60,357 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Owen J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 10,003 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | John B. Williams | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 73,284 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Robert A. Jeffe | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 47,747 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | R. Jay Gerken | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 44,794 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Kristen M. Ludgate | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 10,003 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael J. Haddad | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 8,640 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Rodney Jones-Tyson | Director | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,585 | 13,822 (0%) | 0% | 27.3 | 124,987 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | John A. Utz | Executive Vice President | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,494 | 114,898 (0%) | 0% | 27.3 | 122,506 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Steven S. Zandpour | EVP | Grant, award, or other acquisition of securities at price $ 27.26 per share. | 01 Feb 2026 | 4,428 | 18,997 (0%) | 0% | 27.3 | 120,707 | Common Stock $0.01 Par Value |
| APA | Ben C. Rodgers | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 4,222 | 42,919 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.